MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators

MJH Life Sciences®, already the largest privately held medical media company in North America, has expanded its reach yet again with a major acquisition.

MJH, the parent company of Pharmaceutical Executive and more than 60 premier healthcare brands, announced Wednesday the acquisition of BPD Healthcare™, a leading tech-enabled marketing and communications firm that partners with health systems and innovators.

The acquisition brings together MJH Life Sciences’ extensive relationships with clinicians, researchers, and healthcare organizations and BPD Healthcare’s expertise in data-driven marketing and strategic communications. The combined strengths of the two companies aim to help health systems and life sciences organizations better navigate the industry’s rapid transformation.

“This is about building a powerful bridge between the science that transforms lives and the systems that deliver that transformation,” said Michael J. Hennessy Jr., chairman and CEO of MJH Life Sciences, in a statement. “BPD shares our unwavering belief that when innovation meets communication, healthcare moves forward.”

BPD serves as a strategic growth partner to many of the nation’s leading health systems, academic medical centers, and healthcare innovators, including HCA Healthcare, Advent Health, Johnson & Johnson, University of California Health System and Google Health, among many others.

The company helps its clients address complex business challenges such as patient acquisition, market assessments, physician referrals, payer negotiations, and talent recruitment—areas that have grown increasingly critical as hospitals face margin pressures and greater competition for both patients and staff. Offerings include integrated branding, marketing, communications, and business consulting services that are supported by proprietary data infused with artificial intelligence.

“BPD shares our unwavering belief that when innovation meets communication, healthcare moves forward.” —Michael J. Hennessy Jr.

Jason Brown, CEO of BPD, said joining MJH Life Sciences allows his company to scale those capabilities and deliver greater value across the healthcare ecosystem.

“Healthcare is changing faster than ever, and the organizations that thrive will be the ones that connect meaning with action,” Brown said. “Joining MJH Life Sciences allows BPD to bring that connection to life on a much larger scale. Together, we can help our clients not just grow their brands but strengthen and innovate the industry to better care for patients and communities.”

MJH Life Sciences reaches more than 7 million physicians, pharmacists, and managed care professionals via its digital, print and live event platforms. Building relationships has been a key driver of the company’s growth: MJH has created more than 800 partnerships with associations, advocacy groups, academic medical systems and community cancer centers, and maintains trusted relationships with hundreds of thought leaders, researchers and medical directors across multiple specialties and healthcare fields. The company produces over 2,500 live and virtual events annually and 300 hours of video content per month through studios around the globe and at its state-of-the-art studio in Cranbury, New Jersey.

“Healthcare is changing faster than ever, and the organizations that thrive will be the ones that connect meaning with action." —Jason Brown

MJH has grown quickly in recent years, expanding both its reach and scope in the healthcare space. In 2019, the company acquired a number of media properties from UBM Life Sciences Group, expanding its reach by adding brands such as Pharmaceutical Executive, Medical Economics, Drug Topics, Dermatology Times, DVM360, and others.

In 2021, the company announced a long-term partnership with BDT Capital Partners, which provides family- and founder-led businesses with long-term, differentiated capital. In 2023, MJH acquired Mesmerize, a company that specializes in patient education at the point of care. Earlier this year, MJH expanded its influence into the aesthetics space with the acquisition of NewBeauty.

In terms of closing the deal, Houlihan Lokey and William Blair served as financial advisers to BPD, with McDermott Will & Schulte providing legal counsel. Day Pitney represented MJH Life Sciences.

BPD, which was founded in 2002 in Boca Raton, Florida, will continue to operate under its existing brand as a wholly owned subsidiary of MJH. Brown will remain CEO and report to Hennessy. The integration is designed to expand both companies’ ability to deliver measurable, data-rich solutions that improve engagement across the healthcare continuum—from discovery to delivery.

“Together, we’re not just connecting information, we’re accelerating how health systems, hospitals, and organizations reach patients and redefine what state-of-the-art care looks and feels like,” Hennessy said.